Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Global Grwth Regulatory News (CMPG)

Share Price Information for Ct Global Grwth (CMPG)

Share Price is delayed by 15 minutes
Get Live Data
323.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (1.875%)
Market Cap: £307.21m
CMPG Live PriceLast checked at - London Stock Exchange

Intraday Ct Global Grwth Share Chart

Directorate change

19 Feb 2026 11:08

RNS Number : 7012T
CT Global Managed Portfolio Trust
19 February 2026
 

To: RNS

From: CT Global Managed Portfolio Trust PLC

Date: 19 February 2026

LEI: 213800ZA6TW45NM9YY31

 

 

CT Global Managed Portfolio Trust PLC ('the Company')

 

Directorate Change

 

Appointment of Non-Executive Director and Chair of the Marketing Committee

Information disclosed in accordance with paragraph 6.4.6R of the Financial Conduct Authority's UK Listing Rules.

 

Following a formal recruitment process and a search conducted by an independent agency, the Board of the Company is pleased to announce the appointment of Roland Spencer as a non-executive director of the Company with effect from 19 February 2026. From this date, Roland will also chair the Marketing Committee, in place of David Warnock.

 

Roland has twenty-five years' experience in the financial sector, including eighteen years in the UK direct‑to‑consumer investments and platform market. His most recent role was Head of New Business at AJ Bell where he previously held a number of senior positions covering AJ Bell Media, corporate development, marketing and product proposition between 2012 to 2025. A recognised industry expert, Roland is a regular speaker at events on retail investor engagement.

 

Roland Spencer, and his Persons Closely Associated to him, do not own any Income shares or Growth shares in the Company and his election will be proposed to shareholders for approval at the Annual General Meeting of the Company currently scheduled to be held in September 2026.

 

There is no other information required to be disclosed pursuant to paragraph 6.4.8R of the Financial Conduct Authority's UK Listing Rules in relation to this appointment.

 

David Warnock, Chairman commented:

 

'We are delighted to welcome Roland as a non-executive director of the Company and believe that his experience of marketing, the direct-to-consumer market and retail investor engagement will add considerable value to the Board.'

 

 

For further information contact:

 

Ian Ridge

Columbia Threadneedle Investment Business Limited

Company Secretary

 

Tel: 0131 573 8300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPURUPUPQGGB
Date   Source Headline
15th Jan 202612:04 pmRNSNet Asset Value(s)
14th Jan 202612:04 pmRNSNet Asset Value(s)
13th Jan 20264:56 pmRNSIssue of Equity
13th Jan 202612:47 pmRNSNet Asset Value(s)
12th Jan 20264:40 pmRNSIssue of Equity
12th Jan 202612:52 pmRNSNet Asset Value(s)
9th Jan 202612:42 pmRNSNet Asset Value(s)
8th Jan 20261:03 pmRNSNet Asset Value(s)
7th Jan 20264:12 pmRNSIssue of Equity
7th Jan 202612:34 pmRNSNet Asset Value(s)
6th Jan 20264:37 pmRNSIssue of Equity
6th Jan 202612:15 pmRNSNet Asset Value(s)
5th Jan 202612:58 pmRNSNet Asset Value(s)
2nd Jan 20263:48 pmRNSIssue of Equity
2nd Jan 202612:46 pmRNSNet Asset Value(s)
2nd Jan 202612:34 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSChair of the Marketing Committee
2nd Jan 20267:00 amRNSChair of the Marketing Committee
31st Dec 202512:56 pmRNSNet Asset Value(s)
30th Dec 20253:05 pmRNSIssue of Equity
30th Dec 20253:05 pmRNSIssue of Equity
30th Dec 202512:36 pmRNSNet Asset Value(s)
29th Dec 20254:39 pmRNSIssue of Equity
29th Dec 20254:39 pmRNSIssue of Equity
29th Dec 20251:34 pmRNSNet Asset Value(s)
24th Dec 202512:08 pmRNSNet Asset Value(s)
23rd Dec 20251:25 pmRNSIssue of Equity
23rd Dec 20251:25 pmRNSIssue of Equity
23rd Dec 202512:46 pmRNSNet Asset Value(s)
22nd Dec 20251:00 pmRNSNet Asset Value(s)
19th Dec 20252:54 pmRNSIssue of Equity
19th Dec 20252:54 pmRNSIssue of Equity
19th Dec 202512:49 pmRNSNet Asset Value(s)
19th Dec 20258:57 amRNSPortfolio Update
19th Dec 20258:57 amRNSPortfolio Update
18th Dec 20253:44 pmRNSIssue of Equity
18th Dec 20253:44 pmRNSIssue of Equity
18th Dec 202512:38 pmRNSNet Asset Value(s)
17th Dec 20254:04 pmRNSIssue of Equity
17th Dec 202512:33 pmRNSNet Asset Value(s)
16th Dec 202512:49 pmRNSNet Asset Value(s)
15th Dec 20254:31 pmRNSIssue of Equity
15th Dec 202512:42 pmRNSNet Asset Value(s)
12th Dec 20253:01 pmRNSIssue of Equity
12th Dec 202512:54 pmRNSNet Asset Value(s)
11th Dec 202512:41 pmRNSNet Asset Value(s)
10th Dec 202512:34 pmRNSNet Asset Value(s)
9th Dec 20253:39 pmRNSIssue of Equity
9th Dec 202512:41 pmRNSNet Asset Value(s)
8th Dec 202512:39 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.